Chemomab Therapeutics Ltd. Increase (Decrease) in Prepaid Expense
Chemomab Therapeutics Ltd. (CMMB) reported Increase (Decrease) in Prepaid Expense of -$975.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2020-03-17
- Chemomab Therapeutics Ltd. increase (decrease) in prepaid expense for fiscal 2019 was -$975.00K, a 725.00% decline from fiscal 2018.
- Chemomab Therapeutics Ltd. increase (decrease) in prepaid expense for fiscal 2018 was $156.00K.
| Period end | Increase (Decrease) in Prepaid Expense 12 month |
|---|---|
| 2019-12-31 | -$975.00K 10-K · filed 2020-03-17 |
| 2018-12-31 | $156.00K 10-K · filed 2020-03-17 |